Q4 2016 13F Holders as of 31 Dec 2016
-
Type / Class
-
Equity / ISHARES BIOTECH
-
Number of holders
-
522
-
Total 13F shares, excl. options
-
15,589,448
-
Shares change
-
-561,850
-
Total reported value, excl. options
-
$4,135,825,810
-
Value change
-
-$145,086,739
-
Put/Call ratio
-
160%
-
Number of buys
-
259
-
Number of sells
-
-204
-
Price
-
$265.38
Significant Holders of ISHARES TR - ISHARES BIOTECH (IBB) as of Q4 2016
637 filings reported holding IBB - ISHARES TR - ISHARES BIOTECH as of Q4 2016.
ISHARES TR - ISHARES BIOTECH (IBB) has 522 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 15,589,448 shares
.
Largest 10 shareholders include BANK OF AMERICA CORP /DE/ (1,888,402 shares), MORGAN STANLEY (1,525,591 shares), CITIGROUP INC (1,236,617 shares), GOLDMAN SACHS GROUP INC (1,025,558 shares), UBS Group AG (664,012 shares), JPMORGAN CHASE & CO (536,721 shares), ROYAL BANK OF CANADA (344,743 shares), ALLIANCEBERNSTEIN L.P. (341,785 shares), BNP PARIBAS ARBITRAGE, SA (284,615 shares), and WELLS FARGO & COMPANY/MN (243,732 shares).
This table shows the top 522 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.